Our experts launched a study to determine the effects of Low Dose naltrexone and NAD+ on Long COVID. The results could move us closer to an FDA-approved treatment for Long COVID.
Could aging science help shed light on a hope for long COVID? Join us as we take a deep dive into how longevity research intersects with long COVID in the first part of our series on long COVID.